MODGRAPH CONSULTANTS LTD

History

Modgraph is a privately-held company, incorporated in the UK. The Company is made up primarily of a team of highly experienced programmers, each with over 20 years experience in scientific software development. Modgraph Consultants Ltd was incorporated in 1993.

Much of Modgraph's early work was involved with database integration, specifically the integration of corporate databases of chemical structures and related property information from a variety of sources.

In 1994 Modgraph began building the corporate registration system for what was then Glaxo. Modgraph was closely involved in the merger of Glaxo and Wellcome and in migrating all data into the registry system during 1995 and 1996; Modgraph also was closely involved in the merger of GlaxoWellcome and Smith Klein Beecham in 2000 to form what is now GSK, and in migrating all data into the merged registry system.

In 1998 Modgraph began to receive interest from other companies in the registration system that was developed for GSK and began legal negotiations with GSK to receive the Intellectual Property for the registration system. This was finally completed in 2000.

Modgraph has since built several chemical-registry systems, including Structural GenomiX in the USA and and by Celltech and Evotec AOI in the UK. A case study of the Celltech project can be found on the Daylight web site.

In 2002 Modgraph was established in the USA and is managed by Mr Craig James. Mr James previously was Senior Database Engineer at Daylight, and Chief Software Architect at Accelrys.

Modgraph has recently expanded its product offerings to include web-base cheminformatics interfaces and chemical-suppliers catalogue system, as well as a preclinical IT Sample management/tracking system and a proton NMR and C13 NMR prediction program.